Ventilator Settings for Bronchoscopy During Mechanical Ventilation: a Randomized Controlled Study
- Conditions
- Fiberoptic BronchoscopyCritical IllnessMechanical Ventilation ComplicationAcute Respiratory Failure
- Interventions
- Other: specific ventilator settings
- Registration Number
- NCT06562725
- Lead Sponsor
- Centre Hospitalier Arras
- Brief Summary
Fiberoptic bronchoscopy (FOB) can cause a significant increase in respiratory resistances and airway pressure during mechanical ventilation (MV), which can jeopardize the delivery of the ventilatory assistance. This randomized controlled study tests the hypothesis that new ventilator settings aimed at reducing airway pressure may facilitate FOB during MV. Results of this trial should lead to propose a new ventilatory strategy for critically ill patients needing a FOB procedure under MV.
- Detailed Description
Introduction : Fiberoptic bronchoscopy (FOB) during mechanical ventilation (MV) is a challenging procedure as it considerably reduces the endotracheal tube internal diameter, increasing respiratory resistances, which may compromise the delivering of the ventilatory assistance. According to respiratory physiology principles applied to MV, the reduction of inspiratory flow and tidal volume are likely to reduce airway pressure during the inspiratory phase when respiratory resistances increase. Based on this assumption, we propose new ventilator settings aimed at reducing airway pressure during FOB. This study represents the first investigation to test special ventilator settings in order to facilitate FOB during MV.
Methods and analysis : This is a single-center randomized controlled trial, in which intubated patients undergoing a FOB will be assigned (1/1) either to receive the new ventilatory strategy or to stay on the ventilator settings previously selected by the attending physician. The intervention group will be applied the specific ventilator settings (inspiratory flow \<25 L/min, tidal volume = 5 mL/Kg, inspiratory time = 1 sec, respiratory frequency \<20c/min, positive end expiratory pressure(PEEP) = 5 cmH2O). The primary endpoint will be the reduction of the occurrence of a serious adverse event - inability to deliver the ventilatory support, significant arterial desaturation, or hemodynamics instability - during FOB prompting the interruption of the procedure. The sample size was estimated at a minimum of 46 patients to demonstrate a 50% reduction in the occurrence of such a serious adverse event with a power of 90% and an alpha risk of 0.05 (paired Student t-test).
Results of this trial should lead to propose a new ventilatory strategy for critically ill patients needing a FOB procedure under MV.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 46
- Age ≥18 years;
- Acute respiratory failure requiring invasive mechanical ventilation in the intensive care unit;
- Indication of either a fiberoptic bronchoscopy (FOB) procedure or a percutaneous tracheostomy under FOB control;
- Patient under sedation with Richmond Agitation and Sedation Scale(RASS) ≤-2,
- Written informed consent obtained by the patient or the patient legal representative
- Presence of an absolute contraindication to FOB (respiratory arrest, severe acute respiratory distress syndrome (ARDS), refractory shock, uncontrolled heart rhythm disorder);
- Patients in respiratory distress or with severe patient-ventilator desynchronies ;
- Patients refusing FOB;
- Pregnancy ;
- Moribund patients (according to American Society of Anesthesiologists (ASA) Physical status score classification, class 5: high probability of death within 24 hours) or at high risk of death during the FOB procedure;
- Patients deprived of liberty;
- Patients under curators or guardianship.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description specific ventilator settings specific ventilator settings Patients randomized in the experimental group "special ventilator settings" will receive ventilator settings aimed at reducing airway pressure during FOB. This includes : inspiratory flow \<25 L/min, tidal volume = 5 mL/Kg, inspiratory time = 1 sec, respiratory frequency \<20c/min, PEEP = 5 cmH2O, and FiO2 = 100%
- Primary Outcome Measures
Name Time Method Determine if the use of specific ventilator settings facilitates the performance of fiberoptic bronchoscopy (FOB) during mechanical ventilation compared to conventional ventilator settings. 5 minutes after bronchoscopy initiation Occurrence of a serious adverse - ventilatory, respiratory, or circulatory - event prompting the procedure to be interrupted early in the first 5 minutes.
- Secondary Outcome Measures
Name Time Method determine if the specific ventilator settings prevent significant hypoventilation during FOB 5 minutes after bronchoscopy initiation Significant reduction in minute ventilation during FOB compared to its initial value
determine if the specific ventilator settings prevent significant arterial oxygen desaturation during FOB 5 minutes after bronchoscopy initiation Significant decrease in the "partial pressure of oxygen in arterial blood (PaO2)"/FiO2 ratio during FOB compared to its initial value
determine if the specific ventilator settings prevent significant hypercapnia during FOB 5 minutes after bronchoscopy initiation Significant increase in PaCO2 during FOB compared to its initial value
determine if the specific ventilator settings reduce the incidence of hemodynamic adverse event 5 minutes after bronchoscopy initiation Significant reduction in episodes of tachycardia, arrythmia, or circulatory instability occurring during the procedure
Trial Locations
- Locations (1)
Arras Hospital
🇫🇷Arras, France